Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication

BACKGROUND: Neoadjuvant endocrine therapy (NET) can improve surgical outcomes in postmenopausal patients with hormone receptor-positive breast cancer. The Ki67 labelling index after NET has a better prognostic power than that at baseline. However, it remains unknown whether a multigene assay with po...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:ESMO Open
Prif Awduron: Ueno, Takayuki, Saji, Shigehira, Masuda, Norikazu, Iwata, Hiroji, Kuroi, Katsumasa, Sato, Nobuaki, Takei, Hiroyuki, Yamamoto, Yutaka, Ohno, Shinji, Yamashita, Hiroko, Hisamatsu, Kazufumi, Aogi, Kenjiro, Sasano, Hironobu, Toi, Masakazu
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2019
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6435245/
https://ncbi.nlm.nih.gov/pubmed/30962956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2018-000476
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg